Given that Wnt signaling is highly activated in CRC progression, we further treated CRC cells with Wnt signaling inhibitor, NCB0846, and the immunoblotting and qRT‐PCR results showed that NCB0846 treatment reduced eIF3f expression in dose‐dependent manners (Figure 6A,B). The gene discussed is EIF3F; the disease is colorectal carcinoma.